🏥FDA Workshop on Optimizing Pregnancy Registries
Optimizing Pregnancy Registries; Public Workshop
Summary
The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public workshop entitled "Optimizing Pregnancy Registries." The purpose of the public workshop is to discuss challenges in designing and implementing pregnancy registries and to consider innovative approaches to improve the design and conduct of pregnancy registries to inform the safety of drug and biological products during pregnancy. This public workshop is being held in collaboration with the University of Maryland Center of Excellence in Regulatory Science and Innovation program.
Agencies
- Health and Human Services Department
- Food and Drug Administration
Business Impact
$$ - Med
The public workshop focuses on optimizing pregnancy registries, discussing regulatory strategies and safety data implications for drug and biological product safety during pregnancy. Business owners in the pharmaceutical and healthcare sectors should consider engagement in these discussions, as the outcomes could influence product development and regulatory compliance requirements.